Several players have opted to modernize their conventional testing models with organ-on-chip products and technologies. These novel products have the potential to transform the drug discovery process by simulating the human physiological and functional environment on a microfluidic system. In addition, these organ-on-chip models not only reduce the need for animal testing model but are also capable of speeding-up the research and precise evaluation of drug toxicity and cellular responses.
By 2035, the financial opportunity within the organ-on-chip market has been analyzed across the following segments:
Type of Product
Organ(s) based
Disease(s) based
Type of Application Area
Drug Discovery and Toxicity Testing
Cancer Research
Tissue Engineering and Regenerative Medicine
Stem Cell Research
Purpose
Research Use
Therapy Development
Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World (RoW)
The Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies 2022-2035 report features the following companies, which we identified to be key players in this domain:
BEOnChip
Dynamic42
Emulate
MIMETAS
SynVivo
TissUse
uFluidix
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
1. Organ-on-Chip: Market Landscape
2. Organ-on-Chip Developers: Company Profiles
3. Patent Analysis
4. Brand Positioning Matrix
5. Academic Grants Analysis
6. Partnerships and Collaborations
7. Funding and Investment Analysis
8. Case Study: Scaffold-Free 3D Cell Culture Systems
9. Organ-on-Chip: Market Forecast and Opportunity Analysis
10. Conclusion
14. Executive Insights
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html
You may also be interested in the following titles:
About Roots Analysis
Roots Analysisis a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
